Table 3 Final main effects linear model of the association between baseline explanatory variables and day 7 lumefantrine concentration in ng/mL (433 patients).

lower

upper

referred from hospital OPD (vs. from outlying clinics)

-198.3

-316.9

-63.1

0.005

unsupervised treatment

-463.3

-536.8

-381.0

<0.0001

age

   ≥15 years

[reference]

<0.0001

   5–14 years

-54.6

-233.3

158.4

0.591

   <5 years

-357.9

-483.8

-208.6

<0.0001

lumefantrine dose (mg/Kg)

   ≥80

[reference]

0.375

   65–79

-168.6

-319.3

9.1

0.062

   50–64

-187.5

-348.4

5.1

0.056

   <50

-36.1

-287.0

286.8

0.806

gametocytaemic at inclusion

395.2

89.5

775.7

0.009

history of dizziness at inclusion

-284.4

-414.9

-131.1

0.001

constant